NASDAQ:IRON
Disc Medicine, Inc.
Disc Medicine, Inc. reported net income of −$212.2M in fiscal 2025. Free cash flow was −$181.3M, and the diluted share count rose 27.9%.Summary generated from Disc Medicine, Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROIC−39.0%
Return on equity−35.9%
Debt / equity0.04
Free cash flow−$181.3M
FCF marginn/a
Share count change+27.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −31 | −47 | −91 | −130 | −236 |
| Net income | −36 | −47 | −76 | −109 | −212 |
| Free cash flow | −28 | −42 | −74 | −94 | −181 |
Recent filings
- 4Insider transaction report
Sep 16, 2026 - 4Insider transaction report
Sep 15, 2026 - 8-KRegulation FD disclosure
Sep 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 30, 2026 - 8-KResults of operations and financial condition
Jul 30, 2026 - 8-KEntry into a material agreement
Jun 30, 2026 - 8-KResults of a shareholder vote
Jun 24, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026